Does Abbott Laboratories (NYSE:ABT) have deteriorating prospects?

The stock of Abbott Laboratories (NYSE:ABT) last traded at $100.67, down -0.88% from the previous session. Data from the available sources indicates that Abbott Laboratories (NYSE:ABT) is covered by 25 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $136.00 and […]

There’s Still Time to Buy Abbott Laboratories (NYSE:ABT) Stock

In yesterday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $103.87, up 1.05% from the previous session. 25 analysts cover Abbott Laboratories (NYSE:ABT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $136.00 and a low of […]

Before You Invest In Abbott Laboratories (NYSE:ABT), Consider This Metric

Stocks of Abbott Laboratories (NYSE:ABT) traded higher last session on Wall Street, down -0.02% to $105.13. According to the data, Abbott Laboratories (NYSE:ABT) has 25 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $136.00 and a low […]

Can Abbott Laboratories (ABT) stock recover despite sales dropping?

In yesterday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $104.93, up 0.38% from the previous session. 25 analysts cover Abbott Laboratories (NYSE:ABT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $136.00 and a low of […]